Copyright Reports & Markets. All rights reserved.

Global Astragaloside IV Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Astragaloside IV
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Astragaloside IV Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 0.1
    • 1.3.3 0.98
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Astragaloside IV Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Food Industry
    • 1.4.3 Pharmaceuticals Industry
    • 1.4.4 Others
  • 1.5 Global Astragaloside IV Market Size & Forecast
    • 1.5.1 Global Astragaloside IV Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Astragaloside IV Sales Quantity (2019-2030)
    • 1.5.3 Global Astragaloside IV Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 NandR Bio Industries
    • 2.1.1 NandR Bio Industries Details
    • 2.1.2 NandR Bio Industries Major Business
    • 2.1.3 NandR Bio Industries Astragaloside IV Product and Services
    • 2.1.4 NandR Bio Industries Astragaloside IV Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 NandR Bio Industries Recent Developments/Updates
  • 2.2 Zenergy Korea Corporation
    • 2.2.1 Zenergy Korea Corporation Details
    • 2.2.2 Zenergy Korea Corporation Major Business
    • 2.2.3 Zenergy Korea Corporation Astragaloside IV Product and Services
    • 2.2.4 Zenergy Korea Corporation Astragaloside IV Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Zenergy Korea Corporation Recent Developments/Updates
  • 2.3 Bio-norm
    • 2.3.1 Bio-norm Details
    • 2.3.2 Bio-norm Major Business
    • 2.3.3 Bio-norm Astragaloside IV Product and Services
    • 2.3.4 Bio-norm Astragaloside IV Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Bio-norm Recent Developments/Updates
  • 2.4 Wuhan Vanz Pharm
    • 2.4.1 Wuhan Vanz Pharm Details
    • 2.4.2 Wuhan Vanz Pharm Major Business
    • 2.4.3 Wuhan Vanz Pharm Astragaloside IV Product and Services
    • 2.4.4 Wuhan Vanz Pharm Astragaloside IV Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Wuhan Vanz Pharm Recent Developments/Updates
  • 2.5 Shaanxi Pioneer Biotech
    • 2.5.1 Shaanxi Pioneer Biotech Details
    • 2.5.2 Shaanxi Pioneer Biotech Major Business
    • 2.5.3 Shaanxi Pioneer Biotech Astragaloside IV Product and Services
    • 2.5.4 Shaanxi Pioneer Biotech Astragaloside IV Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Shaanxi Pioneer Biotech Recent Developments/Updates
  • 2.6 Xi'an Lyphar Biotech
    • 2.6.1 Xi'an Lyphar Biotech Details
    • 2.6.2 Xi'an Lyphar Biotech Major Business
    • 2.6.3 Xi'an Lyphar Biotech Astragaloside IV Product and Services
    • 2.6.4 Xi'an Lyphar Biotech Astragaloside IV Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Xi'an Lyphar Biotech Recent Developments/Updates
  • 2.7 Xian Pincredit Bio-Tech
    • 2.7.1 Xian Pincredit Bio-Tech Details
    • 2.7.2 Xian Pincredit Bio-Tech Major Business
    • 2.7.3 Xian Pincredit Bio-Tech Astragaloside IV Product and Services
    • 2.7.4 Xian Pincredit Bio-Tech Astragaloside IV Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Xian Pincredit Bio-Tech Recent Developments/Updates
  • 2.8 Shaanxi Fuheng (FH) Biotechnology
    • 2.8.1 Shaanxi Fuheng (FH) Biotechnology Details
    • 2.8.2 Shaanxi Fuheng (FH) Biotechnology Major Business
    • 2.8.3 Shaanxi Fuheng (FH) Biotechnology Astragaloside IV Product and Services
    • 2.8.4 Shaanxi Fuheng (FH) Biotechnology Astragaloside IV Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Shaanxi Fuheng (FH) Biotechnology Recent Developments/Updates
  • 2.9 Nanjing NutriHerb BioTech
    • 2.9.1 Nanjing NutriHerb BioTech Details
    • 2.9.2 Nanjing NutriHerb BioTech Major Business
    • 2.9.3 Nanjing NutriHerb BioTech Astragaloside IV Product and Services
    • 2.9.4 Nanjing NutriHerb BioTech Astragaloside IV Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Nanjing NutriHerb BioTech Recent Developments/Updates

3 Competitive Environment: Astragaloside IV by Manufacturer

  • 3.1 Global Astragaloside IV Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Astragaloside IV Revenue by Manufacturer (2019-2024)
  • 3.3 Global Astragaloside IV Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Astragaloside IV by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Astragaloside IV Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Astragaloside IV Manufacturer Market Share in 2023
  • 3.5 Astragaloside IV Market: Overall Company Footprint Analysis
    • 3.5.1 Astragaloside IV Market: Region Footprint
    • 3.5.2 Astragaloside IV Market: Company Product Type Footprint
    • 3.5.3 Astragaloside IV Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Astragaloside IV Market Size by Region
    • 4.1.1 Global Astragaloside IV Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Astragaloside IV Consumption Value by Region (2019-2030)
    • 4.1.3 Global Astragaloside IV Average Price by Region (2019-2030)
  • 4.2 North America Astragaloside IV Consumption Value (2019-2030)
  • 4.3 Europe Astragaloside IV Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Astragaloside IV Consumption Value (2019-2030)
  • 4.5 South America Astragaloside IV Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Astragaloside IV Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Astragaloside IV Sales Quantity by Type (2019-2030)
  • 5.2 Global Astragaloside IV Consumption Value by Type (2019-2030)
  • 5.3 Global Astragaloside IV Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Astragaloside IV Sales Quantity by Application (2019-2030)
  • 6.2 Global Astragaloside IV Consumption Value by Application (2019-2030)
  • 6.3 Global Astragaloside IV Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Astragaloside IV Sales Quantity by Type (2019-2030)
  • 7.2 North America Astragaloside IV Sales Quantity by Application (2019-2030)
  • 7.3 North America Astragaloside IV Market Size by Country
    • 7.3.1 North America Astragaloside IV Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Astragaloside IV Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Astragaloside IV Sales Quantity by Type (2019-2030)
  • 8.2 Europe Astragaloside IV Sales Quantity by Application (2019-2030)
  • 8.3 Europe Astragaloside IV Market Size by Country
    • 8.3.1 Europe Astragaloside IV Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Astragaloside IV Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Astragaloside IV Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Astragaloside IV Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Astragaloside IV Market Size by Region
    • 9.3.1 Asia-Pacific Astragaloside IV Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Astragaloside IV Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Astragaloside IV Sales Quantity by Type (2019-2030)
  • 10.2 South America Astragaloside IV Sales Quantity by Application (2019-2030)
  • 10.3 South America Astragaloside IV Market Size by Country
    • 10.3.1 South America Astragaloside IV Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Astragaloside IV Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Astragaloside IV Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Astragaloside IV Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Astragaloside IV Market Size by Country
    • 11.3.1 Middle East & Africa Astragaloside IV Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Astragaloside IV Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Astragaloside IV Market Drivers
  • 12.2 Astragaloside IV Market Restraints
  • 12.3 Astragaloside IV Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Astragaloside IV and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Astragaloside IV
  • 13.3 Astragaloside IV Production Process
  • 13.4 Astragaloside IV Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Astragaloside IV Typical Distributors
  • 14.3 Astragaloside IV Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Astragaloside IV market size was valued at USD 74 million in 2023 and is forecast to a readjusted size of USD 92 million by 2030 with a CAGR of 3.2% during review period.
    Astragaloside IV extract from astragalus Root.
    Plant extracts are substances or active substances with desired properties extracted from plant tissue and processed for a specific purpose. It is used in various fields, such as health foods, therapeutic drugs, cosmetics, processing aids, additives chemical substitutes. The market’s growth is driven by lifestyle changes, consumer awareness, increasing use of products based on natural ingredients, and biotechnology breakthroughs. Additionally, macroeconomic variables such as rising consumer disposable income, research and development, imports and exports, growth in the agriculture industry, population aging, and population growth have positively impacted the demand for plant extracts in recent years. It is also becoming increasingly popular in cosmetics, perfumes, pharmaceuticals, and dietary supplements. The plant extracts market was valued at USD 31.84 billion in 2022 and is expected to grow at a CAGR of 11.3% during the forecast period.
    The Global Info Research report includes an overview of the development of the Astragaloside IV industry chain, the market status of Food Industry (0.1, 0.98), Pharmaceuticals Industry (0.1, 0.98), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Astragaloside IV.
    Regionally, the report analyzes the Astragaloside IV markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Astragaloside IV market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Astragaloside IV market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Astragaloside IV industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (MT), revenue generated, and market share of different by Type (e.g., 0.1, 0.98).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Astragaloside IV market.
    Regional Analysis: The report involves examining the Astragaloside IV market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Astragaloside IV market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Astragaloside IV:
    Company Analysis: Report covers individual Astragaloside IV manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Astragaloside IV This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Food Industry, Pharmaceuticals Industry).
    Technology Analysis: Report covers specific technologies relevant to Astragaloside IV. It assesses the current state, advancements, and potential future developments in Astragaloside IV areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Astragaloside IV market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Astragaloside IV market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    0.1
    0.98
    Others
    Market segment by Application
    Food Industry
    Pharmaceuticals Industry
    Others
    Major players covered
    NandR Bio Industries
    Zenergy Korea Corporation
    Bio-norm
    Wuhan Vanz Pharm
    Shaanxi Pioneer Biotech
    Xi'an Lyphar Biotech
    Xian Pincredit Bio-Tech
    Shaanxi Fuheng (FH) Biotechnology
    Nanjing NutriHerb BioTech
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Astragaloside IV product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Astragaloside IV, with price, sales, revenue and global market share of Astragaloside IV from 2019 to 2024.
    Chapter 3, the Astragaloside IV competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Astragaloside IV breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Astragaloside IV market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Astragaloside IV.
    Chapter 14 and 15, to describe Astragaloside IV sales channel, distributors, customers, research findings and conclusion.

    Buy now